Acute exacerbation of rheumatoid arthritis-associated interstitial lung disease triggered by COVID-19: What is the best practice for treatment?

We present a case of 79-year-old female with rheumatoid arthritis-associated interstitial lung disease (RA-ILD) developed an acute exacerbation (AE) triggered by coronavirus disease 2019 (COVID-19). The patient was unresponsive to a combination therapy of remdesivir, dexamethasone, and tocilizumab....

Descripción completa

Detalles Bibliográficos
Autores principales: Yonezawa, Toshiyuki, Suzuki, Atsushi, Fukumitsu, Kensuke, Katano, Takuma, Kako, Hisashi, Ishii, Makoto, Niimi, Akio, Imaizumi, Kazuyoshi, Sakamoto, Koji, Omote, Norihito, Yamaguchi, Etsuro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10125217/
https://www.ncbi.nlm.nih.gov/pubmed/37124053
http://dx.doi.org/10.1016/j.rmcr.2023.101857
_version_ 1785029987203547136
author Yonezawa, Toshiyuki
Suzuki, Atsushi
Fukumitsu, Kensuke
Katano, Takuma
Kako, Hisashi
Ishii, Makoto
Niimi, Akio
Imaizumi, Kazuyoshi
Sakamoto, Koji
Omote, Norihito
Yamaguchi, Etsuro
author_facet Yonezawa, Toshiyuki
Suzuki, Atsushi
Fukumitsu, Kensuke
Katano, Takuma
Kako, Hisashi
Ishii, Makoto
Niimi, Akio
Imaizumi, Kazuyoshi
Sakamoto, Koji
Omote, Norihito
Yamaguchi, Etsuro
author_sort Yonezawa, Toshiyuki
collection PubMed
description We present a case of 79-year-old female with rheumatoid arthritis-associated interstitial lung disease (RA-ILD) developed an acute exacerbation (AE) triggered by coronavirus disease 2019 (COVID-19). The patient was unresponsive to a combination therapy of remdesivir, dexamethasone, and tocilizumab. Given that a recent multicenter cohort study reported ILD as a poor prognostic contributor in patients with RA and COVID-19, there may be potentially a certain number of patients with AE of RA-ILD triggered by COVID-19. This case highlights the need for a discussion how to treat these patients in a daily clinical practice.
format Online
Article
Text
id pubmed-10125217
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-101252172023-04-25 Acute exacerbation of rheumatoid arthritis-associated interstitial lung disease triggered by COVID-19: What is the best practice for treatment? Yonezawa, Toshiyuki Suzuki, Atsushi Fukumitsu, Kensuke Katano, Takuma Kako, Hisashi Ishii, Makoto Niimi, Akio Imaizumi, Kazuyoshi Sakamoto, Koji Omote, Norihito Yamaguchi, Etsuro Respir Med Case Rep Case Report We present a case of 79-year-old female with rheumatoid arthritis-associated interstitial lung disease (RA-ILD) developed an acute exacerbation (AE) triggered by coronavirus disease 2019 (COVID-19). The patient was unresponsive to a combination therapy of remdesivir, dexamethasone, and tocilizumab. Given that a recent multicenter cohort study reported ILD as a poor prognostic contributor in patients with RA and COVID-19, there may be potentially a certain number of patients with AE of RA-ILD triggered by COVID-19. This case highlights the need for a discussion how to treat these patients in a daily clinical practice. Elsevier 2023-04-25 /pmc/articles/PMC10125217/ /pubmed/37124053 http://dx.doi.org/10.1016/j.rmcr.2023.101857 Text en © 2023 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Case Report
Yonezawa, Toshiyuki
Suzuki, Atsushi
Fukumitsu, Kensuke
Katano, Takuma
Kako, Hisashi
Ishii, Makoto
Niimi, Akio
Imaizumi, Kazuyoshi
Sakamoto, Koji
Omote, Norihito
Yamaguchi, Etsuro
Acute exacerbation of rheumatoid arthritis-associated interstitial lung disease triggered by COVID-19: What is the best practice for treatment?
title Acute exacerbation of rheumatoid arthritis-associated interstitial lung disease triggered by COVID-19: What is the best practice for treatment?
title_full Acute exacerbation of rheumatoid arthritis-associated interstitial lung disease triggered by COVID-19: What is the best practice for treatment?
title_fullStr Acute exacerbation of rheumatoid arthritis-associated interstitial lung disease triggered by COVID-19: What is the best practice for treatment?
title_full_unstemmed Acute exacerbation of rheumatoid arthritis-associated interstitial lung disease triggered by COVID-19: What is the best practice for treatment?
title_short Acute exacerbation of rheumatoid arthritis-associated interstitial lung disease triggered by COVID-19: What is the best practice for treatment?
title_sort acute exacerbation of rheumatoid arthritis-associated interstitial lung disease triggered by covid-19: what is the best practice for treatment?
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10125217/
https://www.ncbi.nlm.nih.gov/pubmed/37124053
http://dx.doi.org/10.1016/j.rmcr.2023.101857
work_keys_str_mv AT yonezawatoshiyuki acuteexacerbationofrheumatoidarthritisassociatedinterstitiallungdiseasetriggeredbycovid19whatisthebestpracticefortreatment
AT suzukiatsushi acuteexacerbationofrheumatoidarthritisassociatedinterstitiallungdiseasetriggeredbycovid19whatisthebestpracticefortreatment
AT fukumitsukensuke acuteexacerbationofrheumatoidarthritisassociatedinterstitiallungdiseasetriggeredbycovid19whatisthebestpracticefortreatment
AT katanotakuma acuteexacerbationofrheumatoidarthritisassociatedinterstitiallungdiseasetriggeredbycovid19whatisthebestpracticefortreatment
AT kakohisashi acuteexacerbationofrheumatoidarthritisassociatedinterstitiallungdiseasetriggeredbycovid19whatisthebestpracticefortreatment
AT ishiimakoto acuteexacerbationofrheumatoidarthritisassociatedinterstitiallungdiseasetriggeredbycovid19whatisthebestpracticefortreatment
AT niimiakio acuteexacerbationofrheumatoidarthritisassociatedinterstitiallungdiseasetriggeredbycovid19whatisthebestpracticefortreatment
AT imaizumikazuyoshi acuteexacerbationofrheumatoidarthritisassociatedinterstitiallungdiseasetriggeredbycovid19whatisthebestpracticefortreatment
AT sakamotokoji acuteexacerbationofrheumatoidarthritisassociatedinterstitiallungdiseasetriggeredbycovid19whatisthebestpracticefortreatment
AT omotenorihito acuteexacerbationofrheumatoidarthritisassociatedinterstitiallungdiseasetriggeredbycovid19whatisthebestpracticefortreatment
AT yamaguchietsuro acuteexacerbationofrheumatoidarthritisassociatedinterstitiallungdiseasetriggeredbycovid19whatisthebestpracticefortreatment

Ejemplares similares